Download PDF
kleintier konkret 2013; 16(3): 3-6
DOI: 10.1055/s-0032-1331135
newsletter|forschung
industrie
Enke Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart

Neues zum Schmerzmanagement – Anwendung von transdermalem Fentanyl für eine anhaltende Analgesie

Daniela Rudowitz
Elanco Animal Health
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2013 (online)

Also available at
    Permissions and Reprints All articles of this category

„Die mangelnde Fähigkeit zur verbalen Kommunikation schließt nicht aus, dass ein Individuum Schmerz empfindet und einer geeigneten Schmerztherapie bedarf.“ [[1]] Mit dieser Aussage stellt die International Association for the Study of Pain (IASP) deutlich heraus, dass auch in der Tiermedizin das Schmerzmanagement immer wieder kritisch überdacht und falls möglich optimiert werden sollte.

 

  • Literatur

  • 1 Internal Association for the Study of Pain. IASP taxonomy. www.iasp-pain.org
    Google Scholar
  • 2 Gaynor JS, Muir WW. Veterinary Pain Management 2002. Mosby; St Louis: 163-170
    Google Scholar
  • 3 Tranquilli WJ. Pain management for Small animal practitioner. 2004; 2: 2-21
    Google Scholar
  • 4 Plumb DonaldC. Plumb’s Veterinary Drug Handbook. Fifth edition Ames, Iowa: Blackwell Publishing; 2005: 553
    Google Scholar
  • 5 Keates HL, Cramond T, Smith MT. Intraarticular and periarticular opioid binding in inflamed tissue in experimental canine arthritis. Anaesth Analg 1999; 89(2): 409-415
    Google Scholar
  • 6 Lascelles BDX Clinical pharmacology of analgesic agents. In: Hellebrekers LJ. Animal Pain. The Netherlands: Van der Wees; 2000: 85-97
    Google Scholar
  • 7 Grant D. Pain Management in Small Animals. Butterworth Heinemann; Elsevier Ltd: 2006
    Google Scholar
  • 8 Murphy MR, Olson WA, Hug CC. Pharmacokinetics of H-fentanyl in the dog, anesthetized under enflurane. Anesthesiology 1979; 50: 13-19
    CrossrefGoogle Scholar
  • 9 Kukanich B, Clark TP. The history and pharmacology of fentanyl: relevance to a novel, long-acting transdermal fentanyl solution newly approved for use in dogs. J. vet. Pharmacol. Therap. 2012; 35 (Suppl. 2): 3-19
    Google Scholar
  • 10 Reed B, Morgan T, Finnin B. United States Patent, #7438203 B2, PatentStorm. http://www patentstorm us
    Google Scholar
  • 11 Bhatt P, Hanna M, Szeptycki P, Higuchi T. Finite Dose Transport of Drugs in Liquid Formulations Through Stratum Corneum: Analytical Solution to a Diffusion Model*. Int J Pharmaceutics 1989; 50: 197-203
    CrossrefGoogle Scholar
  • 12 Fachinformation RecuvyraTM .
    Google Scholar
  • 13 CVMP assessment report of an application for the granting of a community authorisation for Recuvyra™. (EMEA/ V/C/002239) 20.05.2011
    Google Scholar
  • 14 Elanco Study T8F1090406. data on file
    Google Scholar